CHLORTHALIDONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlorthalidone, and what generic alternatives are available?
Chlorthalidone is a drug marketed by Abbott, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Ani Pharms, Appco, Ascot, Barr Labs Inc, Chartwell Rx, Cosette, Dava Pharms Inc, Inventia, Ivax Pharms, Kv Pharm, Mankind Pharma, Mutual Pharm, Mylan, Novast Labs, Pioneer Pharms, Purepac Pharm, Sandoz, Sun Pharm Industries, Sunny, Superpharm, Tagi, Umedica, Unichem, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, and Zydus Pharms. and is included in fifty-eight NDAs.
The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorthalidone
A generic version of CHLORTHALIDONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.
Summary for CHLORTHALIDONE
Recent Clinical Trials for CHLORTHALIDONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Roche Diagnostics | Phase 4 |
Jessa Hospital | Phase 4 |
Vrije Universiteit Brussel | Phase 4 |
Pharmacology for CHLORTHALIDONE
Drug Class | Thiazide-like Diuretic |
Physiological Effect | Increased Diuresis |